2012
DOI: 10.1128/mcb.00062-12
|View full text |Cite
|
Sign up to set email alerts
|

The Hypersensitive Glucocorticoid Response Specifically Regulates Period 1 and Expression of Circadian Genes

Abstract: dGlucocorticoids regulate gene expression by binding and activating the glucocorticoid receptor (GR). While ligand affinity determines the global sensitivity of the response, additional proteins act on the genome to tune sensitivity of some genes. However, the genomic extent and specificity of dose-specific glucocorticoid responses are unknown. We show that dose-specific glucocorticoid responses are extraordinarily specific at the genomic scale, able to distinctly express a single gene, the circadian rhythm ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
118
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 134 publications
(130 citation statements)
references
References 74 publications
11
118
0
1
Order By: Relevance
“…We reanalyzed published data sets (Supplemental Table S5) to test the updated model, including GR binding data under varied dex concentrations and in different cellular contexts. We recapitulated the finding of Reddy et al (2012) that enhancers with GR binding at low dex concentration had increased initial accessibility (dex hypersensitive vs. low-sensitive; Mann-Whitney U test, P = 1.1 × 10 −14 ); however, the difference was starker in terms of initial EP300 (dex hypersensitive vs. low-sensitive; Mann-Whitney U test, P < 10 −100 ) (Fig. 3B,C).…”
Section: Across Cellular Contexts Gr Binds Preferentially To Enhancerssupporting
confidence: 83%
See 1 more Smart Citation
“…We reanalyzed published data sets (Supplemental Table S5) to test the updated model, including GR binding data under varied dex concentrations and in different cellular contexts. We recapitulated the finding of Reddy et al (2012) that enhancers with GR binding at low dex concentration had increased initial accessibility (dex hypersensitive vs. low-sensitive; Mann-Whitney U test, P = 1.1 × 10 −14 ); however, the difference was starker in terms of initial EP300 (dex hypersensitive vs. low-sensitive; Mann-Whitney U test, P < 10 −100 ) (Fig. 3B,C).…”
Section: Across Cellular Contexts Gr Binds Preferentially To Enhancerssupporting
confidence: 83%
“…We reasoned that GR binding sites present at low dex dosages may similarly depend on enhancer interactions, and we confirmed this with a comparable analysis (50 nM and 100 nM, 1 h dex; Mann-Whitney U test, P < 4.07 × 10-21) (Supplemental Fig. S6E; Reddy et al 2012).…”
Section: Enhancer Dynamics Are Dependent Across Neighboring Enhancerssupporting
confidence: 73%
“…First, there was little to no GR occupancy detected under basal culture conditions at binding sites within the KLF15 (Fig. 3B) and PER1 loci, which others have shown are robustly occupied by GR after exposure to low nanomolar concentrations of supplemental ligand (80). Second, whereas GR occupancy was markedly reduced at some sites after dex treatment, other sites had dramatically increased occupancy, and still other regions exhibited minimal changes with the addition of supplemental ligand (see Figs.…”
Section: Discussionmentioning
confidence: 82%
“…What are the mechanisms underlying persistent rhythmicity and loss of rhythmicity? The circadian rhythms of both melatonin and cortisol are known to regulate gene expression (11,43) and are driven by the SCN. The fact that the vast majority of circadian transcripts become arrhythmic when sleeping out of phase with melatonin would indicate that the SCN neural outputs and hormones driven by the SCN (i.e., melatonin and cortisol only has a limited influence on the peripheral blood).…”
Section: Mechanisms Underlying the Temporal Disruption Of Gene Expresmentioning
confidence: 99%
“…Furthermore, physiological factors such as body temperature (10) and endocrine rhythms such as cortisol (11) can modify and reinforce these regulatory processes.…”
mentioning
confidence: 99%